Dr. Mason was named the Company’s Chief Medical Officer in December 2018. He joined MiMedx in June 2014, in the position of Vice President of Medical Affairs for Clinical Programs. Dr. Mason is a Board Certified Internist, board eligible in Rheumatology and Infectious Diseases, whose experience includes a 27-year pharmaceutical and medical device industry career, with increasing levels of responsibility. His experience covers multiple therapeutic areas and includes management of Clinical Development and Medical Affairs groups; Regulatory Affairs including QA; Public Affairs, Public Policy and Public Relations. Dr. Mason has extensive experience in all phases of drug development including preclinical, regulatory and clinical trials from Phases I through IV. His vast experience includes handling IND filings, protocol writing, more than ten successful BLA and NDA submissions, multiple successful 510(k) and de novo device clearances, and a similar number of drug and device product launches.
Before joining MiMedx, Dr. Mason previously served as Senior Vice President and Chief Medical Officer of Given Imaging where he led clinical trials, regulatory affairs and medical marketing initiatives. Before joining Given, Dr. Mason served with UCB Pharma as the company’s Vice President, Clinical Development and Global Head of Inflammation Clinical Research. In this role, Dr. Mason led the U.S. and U.K. teams in support of the regulatory pathways for the company’s portfolio of anti-inflammatory drugs. Dr. Mason also served with AVI BioPharma as its Senior Vice President of Clinical Development and Regulatory Affairs where he led drug development efforts including clinical programs in multiple therapeutic areas.
After medical school, Dr. Mason pursued a 15 year career in medical practice in both academic and private practice settings. During this time, Dr. Mason was a practicing physician in internal medicine, infectious diseases and rheumatology. Following his tenure in medical practice, Dr. Mason began his pharmaceutical and medical device industry career by joining Ciba-Geigy Pharmaceuticals in the capacity of Director, Clinical Research and Executive Director, Medical Affairs.
Dr. Mason has authored more than 15 manuscripts on clinical studies that have been published in peer-reviewed literature. He has authored a textbook article and a number of clinical abstracts that have been published in peer-reviewed journals.
Dr. Mason received his M.D. from Duke University Medical School. He earned a BA in Chemistry from Williams College. He completed an internship and fellowship in Rheumatology at Duke University Hospital and completed his residency in Internal Medicine at the University of Michigan Medical Center. Dr. Mason has also served as a Research Associate and USPHS SA Surgeon (Lt. Comm.) at NIH, NIAID, Laboratory of Viral Diseases, Bethesda, Maryland.